id | Study | Lib. in paper | Exposition period | Study type |
Control type |
Tags | OR 95%CI | x1/n1 x0/n0 | no cases | no exposed | ROB | Ref. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
S3647 R7580 |
Nguyen (control exposed to Glatiramer), 2019 | Pre-term (<37 weeks) | during pregnancy (anytime or not specified) | prospective cohort | exposed to other treatment, sick excluded | Adjustment: No |
0.81 [0.47;1.40] C excluded (control group) |
57/268 24/96 | 81 | 268 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S3648 R7583 |
Nguyen (control unexposed, sick), 2019 | Pre-term (<37 weeks) | during pregnancy (anytime or not specified) | prospective cohort | unexposed, sick | Adjustment: No | 0.75 [0.53;1.05] C | 57/268 182/686 | 239 | 268 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S3716 R7991 |
Thiel (control unexposed, sick), 2016 | Preterm birth | early pregnancy | prospective cohort | unexposed, sick | Adjustment: Yes | 0.64 [0.30;1.37] | 15/227 18/181 | 33 | 227 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S3632 R7438 |
Fragoso a (control exposed to Glatiramer), 2013 | Prematurity (NOS) | during pregnancy (anytime or not specified) | retrospective cohort | exposed to other treatment, sick excluded | Adjustment: No |
6.91 [0.79;60.38] C excluded (control group) |
6/39 1/39 | 7 | 39 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S3633 R7454 |
Fragoso a (control unexposed, sick), 2013 | Prematurity (NOS) | during pregnancy (anytime or not specified) | retrospective cohort | unexposed, sick | Adjustment: No | 5.58 [1.32;23.58] C | 6/39 3/95 | 9 | 39 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S3636 R7513 |
Fragoso b (control exposed to Glatiramer), 2013 | Premature delivery | at least 1st trimester | retrospective cohort | exposed to other treatment, sick excluded | Adjustment: No |
0.80 [0.03;20.62] C excluded (control group) |
0/17 1/41 | 1 | 17 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S3637 R7529 |
Fragoso b (control unexposed, sick), 2013 | Premature delivery | at least 1st trimester | retrospective cohort | unexposed, sick | Adjustment: No | 1.77 [0.07;45.30] C | 0/17 1/89 | 1 | 17 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S3643 R7562 |
Giannini (control exposed to Glatiramer), 2012 | Preterm delivery (NOS) | early pregnancy | prospective cohort | exposed to other treatment, sick excluded | Adjustment: No |
1.47 [0.43;5.02] C excluded (control group) |
25/76 4/16 | 29 | 76 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S3644 R7567 |
Giannini (control unexposed, sick), 2012 | Preterm delivery (NOS) | early pregnancy | prospective cohort | unexposed, sick | Adjustment: Yes | 2.11 [1.18;3.78] | 25/76 58/288 | 83 | 76 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S3613 R7360 |
Weber-Schoendorfer (control exposed to Glatiramer), 2009 | Preterm births | at least 1st trimester | prospective cohort | exposed to other treatment, sick excluded | Adjustment: No |
3.06 [0.35;26.93] C excluded (control group) |
6/53 1/25 | 7 | 53 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S3614 R7364 |
Weber-Schoendorfer (control unexposed, disease free), 2009 | Preterm births | at least 1st trimester | prospective cohort | unexposed, disease free excluded | Adjustment: No |
1.85 [0.62;4.44] excluded (control group) |
6/53 90/1,377 | 96 | 53 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S3615 R7368 |
Weber-Schoendorfer (control unexposed, sick), 2009 | Preterm births | at least 1st trimester | prospective cohort | unexposed, sick | Adjustment: No | 0.75 [0.24;2.33] C | 6/53 8/55 | 14 | 53 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S3723 R8019 |
Boskovic (control unexposed, disease free), 2005 | Preterm birth (< 37 weeks gestation (postconception). | 1st trimester | prospective cohort | unexposed, disease free excluded | Adjustment: No |
1.81 [0.15;21.60] C excluded (control group) |
2/23 1/20 | 3 | 23 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S3724 R8024 |
Boskovic (control unexposed, sick), 2005 | Preterm birth (< 37 weeks gestation (postconception). | 1st trimester | prospective cohort | unexposed, sick | Adjustment: No | 0.57 [0.09;3.81] C | 2/23 3/21 | 5 | 23 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Total | 7 studies | 1.12 [0.63;1.99] | 384 | 703 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
x1: number of endpoints among exposed, n1: number of exposed; x0: number of endpoints among non exposed, n0: number of non exposed; C: calculated odds ratio from numbers of events and effectives |
1: control unexposed, sick; 2: control unexposed, sick; 3: control unexposed, sick; 4: control unexposed, sick; 5: control unexposed, sick; 6: control unexposed, sick; 7: control unexposed, sick;
Asymetry test p-value = 0.4912 (by Egger's regression)
slope=-0.2802 (0.3948); intercept=0.8429 (1.1353); t=0.7424; p=0.4912
excluded 3723, 3613, 3614, 3643, 3632, 3636, 3647